Table 1.
Patient characteristics
| FNA+ | FNA- | ||
| Number of patients | 54 | 28 | |
| Median age (range), yr | 68 (43-82) | 70 (45-84) | NS1 |
| Gender (M/F) | 34/20 | 16/12 | NS2 |
| Location (Ph/Pb/Pt) | 33/17/4 | 20/6/2 | NS2 |
| Median CEA (95%CI), ng/mL | 4.89 (3.6-5.3) | 5.18 (-0.6-45.1) | NS1 |
| Median CA19-9 (95%CI), U/mL | 46.1 (71.5-248.9) | 96.7 (-158.9-1,661.9) | NS1 |
| Median SPan-1 (95%CI), U/mL | 33.65 (40.3-191.0) | 64.5 (-58.3-945.3) | NS1 |
| Median DU-PAN-2 (95%CI), U/mL | 129 (215-726) | 303 (211-630) | NS1 |
1
Mann-Whitney U test;
2
Fisher’s exact test. FNA+: The patient group who underwent endoscopic ultrasound-guided fine-needle aspiration before surgery; FNA-: The patient group who did not undergo endoscopic ultrasound-guided fine-needle aspiration before surgery; NS: No significant difference; Ph: Pancreas head; Pb: Pancreas body; Pt: Pancreas tail; CEA: Carcinoembryonic antigen; CA 19-9: Carbohydrate antigen 19-9.